Clinical Trials Directory

Trials / Completed

CompletedNCT00473915

Intranasal Steroids and the Nasal Ocular Response

Intranasal Steroids Prevent Antigen-Induced Hyperresponsiveness of the Nasal Ocular Response

Status
Completed
Phase
Phase 4
Study type
Interventional
Enrollment
20 (estimated)
Sponsor
University of Chicago · Academic / Other
Sex
All
Age
18 Years – 45 Years
Healthy volunteers
Accepted

Summary

Eye symptoms of tearing, redness and itch frequently occur in patients with allergic rhinitis or hayfever. The purpose of this study is to learn whether placing allergen (the substance that causes allergies) in the nose several days in a row will cause an increase in eye symptoms and whether receiving a nasal steroid spray will prevent these eye symptoms.

Conditions

Interventions

TypeNameDescription
DRUGfluticasone furoatecorticosteroid nasal spray

Timeline

Start date
2007-04-01
Primary completion
2007-12-01
Completion
2008-02-01
First posted
2007-05-16
Last updated
2013-06-03

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT00473915. Inclusion in this directory is not an endorsement.

Intranasal Steroids and the Nasal Ocular Response (NCT00473915) · Clinical Trials Directory